Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q66LE6

Entry ID Method Resolution Chain Position Source
AF-Q66LE6-F1 Predicted AlphaFoldDB

282 variants for Q66LE6

Variant ID(s) Position Change Description Diseaes Association Provenance
CA661812286
rs1340440404
5 G>A No ClinGen
TOPMed
CA661812290
rs1372705272
8 G>A No ClinGen
TOPMed
CA661812291
rs1326247567
9 C>F No ClinGen
TOPMed
CA661812292
rs1326247567
9 C>Y No ClinGen
TOPMed
CA661812294
rs1391665801
10 P>A No ClinGen
TOPMed
rs1330751496
CA661812296
10 P>L No ClinGen
TOPMed
rs1418767018
CA661812298
12 G>D No ClinGen
TOPMed
CA661812297
rs1410497047
12 G>R No ClinGen
TOPMed
rs1397117865
CA661812303
17 Q>H No ClinGen
TOPMed
CA661812305
rs1194514510
19 C>R No ClinGen
TOPMed
CA661812307
rs1245082841
20 F>C No ClinGen
TOPMed
CA661812309
rs1438873521
23 V>L No ClinGen
TOPMed
CA661812313
rs1226640283
26 A>S No ClinGen
TOPMed
rs1350508454
CA661812314
27 I>M No ClinGen
TOPMed
rs782454777
CA5750357
34 A>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 35 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs782294675
CA5750359
37 I>V No ClinGen
ExAC
gnomAD
CA378912331
rs1554896165
40 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1554896166
CA378912356
43 N>S No ClinGen
gnomAD
CA378912362
rs1554896168
44 Y>N No ClinGen
gnomAD
CA378912384
rs1440764642
47 D>G No ClinGen
TOPMed
TCGA novel 48 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 49 L>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs782194730
CA216525110
52 G>R No ClinGen
Ensembl
rs1554896176
CA378912436
55 G>D No ClinGen
gnomAD
CA5750365
rs782065411
56 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA216525114
rs773469374
60 I>V No ClinGen
TOPMed
CA5750367
rs782304722
63 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs782030666
CA5750368
63 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs201069665
CA5750370
65 Q>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA378912501
rs1262358408
65 Q>R No ClinGen
TOPMed
gnomAD
rs781851854
CA5750371
66 E>K No ClinGen
ExAC
rs1316022452
CA378912535
67 N>S No ClinGen
TOPMed
gnomAD
CA5750392
rs782131911
70 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA5750393
rs782779479
70 R>H No ClinGen
ExAC
gnomAD
CA378912564
rs1554896980
71 P>L No ClinGen
gnomAD
CA378912561
rs1554896978
71 P>S No ClinGen
Ensembl
rs1367762327
CA378912567
72 H>L No ClinGen
TOPMed
gnomAD
rs1367762327
CA378912569
72 H>R No ClinGen
TOPMed
gnomAD
rs781838782
CA5750394
72 H>Y No ClinGen
ExAC
gnomAD
rs782474431
CA5750395
74 R>W No ClinGen
ExAC
CA378912584
rs1554896982
75 G>R No ClinGen
gnomAD
CA5750398
rs782551536
78 N>D No ClinGen
ExAC
gnomAD
CA378912616
rs1303969516
79 V>A No ClinGen
TOPMed
rs782662178
CA5750399
79 V>I No ClinGen
ExAC
gnomAD
rs1554896994
CA378912635
82 T>A No ClinGen
gnomAD
CA5750401
rs782488766
82 T>N No ClinGen
ExAC
TOPMed
gnomAD
rs961319905
CA216526349
88 P>L No ClinGen
TOPMed
CA5750404
rs782316872
89 E>G No ClinGen
ExAC
TOPMed
gnomAD
CA378912749
rs1554897006
97 E>D No ClinGen
gnomAD
rs1554897007
CA378912752
98 I>V No ClinGen
gnomAD
CA378912763
rs1269176265
99 E>G No ClinGen
TOPMed
CA5750407
rs782393174
102 I>F No ClinGen
ExAC
gnomAD
rs1589951928
CA378912804
105 I>L No ClinGen
Ensembl
TCGA novel 106 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs782099756
CA5750409
106 R>S No ClinGen
ExAC
gnomAD
rs1554897012
CA378912865
113 A>S No ClinGen
gnomAD
CA5750412
rs782051552
114 A>T No ClinGen
ExAC
gnomAD
CA216526366
rs917160128
114 A>V No ClinGen
Ensembl
rs1554897016
CA378912877
115 H>R No ClinGen
gnomAD
CA5750413
rs782810307
116 F>Y No ClinGen
ExAC
TOPMed
gnomAD
CA5750417
rs781828721
120 T>A No ClinGen
ExAC
gnomAD
CA378912908
rs1554897022
120 T>I No ClinGen
gnomAD
CA5750418
rs782475271
121 N>D No ClinGen
ExAC
TOPMed
gnomAD
CA378912969
rs1554897090
127 L>* No ClinGen
gnomAD
rs1309824555
CA378912970
127 L>F No ClinGen
TOPMed
gnomAD
CA378913016
rs1554897095
133 R>L No ClinGen
gnomAD
rs781983664
CA378913013
133 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA378913020
rs1218468205
134 D>G No ClinGen
TOPMed
gnomAD
CA216526487
rs1049990595
134 D>H No ClinGen
Ensembl
CA378913021
rs1218468205
134 D>V No ClinGen
TOPMed
gnomAD
rs782096545
CA5750435
136 R>K No ClinGen
ExAC
gnomAD
rs1564821233
CA378913091
144 D>G No ClinGen
Ensembl
CA378913095
rs1554897102
145 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1284807879
CA378913113
147 G>* No ClinGen
TOPMed
rs782168628
CA5750438
150 R>G No ClinGen
ExAC
gnomAD
CA378913131
rs1554897104
150 R>Q No ClinGen
gnomAD
CA216526495
rs1006128767
154 R>S No ClinGen
gnomAD
CA5750439
rs782811828
156 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs552691540
CA216526503
157 A>S No ClinGen
1000Genomes
CA378913178
rs1291330487
157 A>V No ClinGen
TOPMed
gnomAD
CA5750444
rs782467232
159 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs781827357
CA5750443
159 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA5750460
rs781792253
162 I>M No ClinGen
ExAC
gnomAD
rs369534966
CA5750459
162 I>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA5750461
rs782542034
165 P>R No ClinGen
ExAC
gnomAD
CA5750462
rs782674547
166 M>T No ClinGen
ExAC
gnomAD
TCGA novel 168 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5750463
rs781865494
168 L>V No ClinGen
ExAC
gnomAD
rs782610991
CA5750465
169 M>I No ClinGen
ExAC
gnomAD
rs782510968
CA5750464
169 M>T No ClinGen
ExAC
TOPMed
gnomAD
rs1288670686
CA378913291
172 A>V No ClinGen
TOPMed
gnomAD
rs1396268030
CA378913297
173 S>T No ClinGen
TOPMed
gnomAD
rs782449204
CA378913312
176 R>G No ClinGen
ExAC
gnomAD
TCGA novel 176 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1165138968
CA378913331
179 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA5750468
rs782688679
180 N>D No ClinGen
ExAC
gnomAD
CA216527201
rs922199967
180 N>S No ClinGen
Ensembl
CA378913362
rs1554897559
183 T>I No ClinGen
gnomAD
TCGA novel 184 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs782390619
CA5750470
185 H>L No ClinGen
ExAC
gnomAD
TCGA novel 188 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5750471
rs781990716
192 N>S No ClinGen
ExAC
gnomAD
rs1186448669
CA378913429
193 S>T No ClinGen
TOPMed
rs1469614951
CA378913441
195 H>N No ClinGen
TOPMed
gnomAD
CA5750473
rs782344692
195 H>R No ClinGen
ExAC
TCGA novel 196 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA378913471
rs886154152
199 L>F No ClinGen
TOPMed
gnomAD
rs886154152
CA216527208
199 L>I No ClinGen
TOPMed
gnomAD
rs1263826751
CA378913489
202 D>Y No ClinGen
TOPMed
rs545914041
CA216527211
205 R>K No ClinGen
Ensembl
CA378913520
rs1554897577
206 I>M No ClinGen
gnomAD
rs1229630608
CA378913549
210 H>R No ClinGen
TOPMed
rs1564822453
CA378913559
211 L>F No ClinGen
Ensembl
rs1327535662
CA378913553
211 L>I No ClinGen
TOPMed
rs782809700
CA5750476
213 I>V No ClinGen
ExAC
gnomAD
rs1295447181
CA378913575
214 T>A No ClinGen
TOPMed
gnomAD
rs782016273
CA5750477
214 T>R No ClinGen
ExAC
gnomAD
rs782125421
CA5750478
217 S>T No ClinGen
ExAC
gnomAD
rs1554897809
CA378913630
220 I>V No ClinGen
gnomAD
CA378913639
rs1554897811
221 V>E No ClinGen
gnomAD
CA378913636
rs1472079336
221 V>M No ClinGen
TOPMed
CA5750508
rs370741632
223 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1554897815
CA378913674
224 K>N No ClinGen
gnomAD
rs373216246
CA5750511
224 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5750512
rs782185774
226 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs782302750
CA5750513
228 M>L No ClinGen
ExAC
gnomAD
TCGA novel 228 M>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5750514
rs782028635
232 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA5750517
rs781979918
235 I>V No ClinGen
ExAC
gnomAD
rs976479435
CA216527580
236 T>S No ClinGen
Ensembl
CA5750519
rs782714817
239 E>K No ClinGen
ExAC
gnomAD
rs1344208198
CA378913946
242 P>L No ClinGen
TOPMed
gnomAD
rs1344208198
CA378913945
242 P>R No ClinGen
TOPMed
gnomAD
CA378913941
rs1226599414
242 P>S No ClinGen
TOPMed
CA5750521
rs782163458
243 H>R No ClinGen
ExAC
gnomAD
rs1227314372
CA378913949
243 H>Y No ClinGen
TOPMed
CA378913965
rs1554897843
245 C>Y No ClinGen
gnomAD
rs1554897844
CA378913970
246 N>H No ClinGen
gnomAD
rs953993191
CA216527588
247 V>M No ClinGen
gnomAD
rs201223480
CA5750524
249 V>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1554897855
CA378914005
251 S>G No ClinGen
gnomAD
CA378914008
rs1564823057
251 S>T No ClinGen
Ensembl
CA378914042
rs1589955833
256 T>P No ClinGen
Ensembl
CA5750527
rs782446670
257 I>V No ClinGen
ExAC
TOPMed
gnomAD
rs782571879
CA5750528
258 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA378914066
rs1423363107
260 C>G No ClinGen
TOPMed
TCGA novel 263 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA378914092
rs1372875285
263 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs782285773
CA5750529
264 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs782403976
CA5750530
265 S>L No ClinGen
ExAC
gnomAD
rs1554897868
CA378914112
267 L>V No ClinGen
gnomAD
rs1554897871
CA378914124
269 D>N No ClinGen
gnomAD
CA5750548
rs562202186
278 P>A No ClinGen
1000Genomes
ExAC
gnomAD
rs782780712
CA5750549
282 S>G No ClinGen
ExAC
gnomAD
rs781860845
CA5750550
283 S>N No ClinGen
ExAC
rs1554898147
CA378914251
284 R>T No ClinGen
gnomAD
CA378914260
rs1564823923
285 S>F No ClinGen
Ensembl
CA378914265
rs1375119545
286 F>S No ClinGen
TOPMed
rs1554898155
CA378914321
294 I>T No ClinGen
gnomAD
rs1554898153
CA378914318
294 I>V No ClinGen
gnomAD
CA378914330
rs1554898157
296 D>N No ClinGen
gnomAD
rs782441161
CA5750555
300 S>N No ClinGen
ExAC
gnomAD
CA216528264
rs61745760
302 S>R No ClinGen
Ensembl
TCGA novel 303 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA216528266
rs766586991
304 R>Q No ClinGen
TOPMed
gnomAD
CA378914417
rs1345676107
307 M>I No ClinGen
TOPMed
gnomAD
CA5750557
rs140820296
310 D>N No ClinGen
1000Genomes
ExAC
gnomAD
CA5750558
rs782395807
313 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs76274320
CA216528279
CA5750560
314 V>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1185717575
CA378914470
316 V>L No ClinGen
TOPMed
rs1445400442
CA378914480
317 W>* No ClinGen
TOPMed
rs782046497
CA5750563
319 L>F No ClinGen
ExAC
gnomAD
rs1554898177
CA378914509
321 M>K No ClinGen
gnomAD
CA378914541
rs1554898180
325 P>L No ClinGen
gnomAD
CA378914536
rs1554898179
325 P>T No ClinGen
gnomAD
rs782121870
CA5750566
327 E>G No ClinGen
ExAC
TOPMed
gnomAD
rs782767004
CA5750567
329 H>R No ClinGen
ExAC
rs868911214
CA378914562
329 H>Y No ClinGen
Ensembl
CA5750570
rs782691603
330 Q>H No ClinGen
ExAC
TOPMed
gnomAD
rs782471400
CA5750569
330 Q>L No ClinGen
ExAC
gnomAD
rs782471400
CA378914572
330 Q>R No ClinGen
ExAC
gnomAD
CA378914582
rs1215664334
332 H>Y No ClinGen
TOPMed
CA378914593
rs782651908
333 E>D No ClinGen
ExAC
gnomAD
CA5750572
rs369435052
333 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs547732352
CA5750574
336 R>C No ClinGen
1000Genomes
ExAC
gnomAD
CA5750575
rs193198132
336 R>H Variant assessed as Somatic; 0.0002783 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA5750576
rs193198132
336 R>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5750577
rs782190671
337 S>R No ClinGen
ExAC
gnomAD
rs1246277757
CA378914618
338 K>Q No ClinGen
TOPMed
CA5750579
rs782027193
340 C>S No ClinGen
ExAC
gnomAD
CA378914641
rs1309998308
341 S>A No ClinGen
TOPMed
CA5750582
rs781971947
343 Y>C No ClinGen
ExAC
gnomAD
rs1554898220
CA378914661
344 E>A No ClinGen
gnomAD
rs879999561
CA378914683
347 C>R No ClinGen
gnomAD
rs1554898224
CA378914712
350 D>E No ClinGen
gnomAD
rs1554898233
CA378914740
354 C>Y No ClinGen
gnomAD
CA378914772
rs1554898239
358 G>A No ClinGen
gnomAD
CA5750587
rs34473884
358 G>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA5750586
rs34473884
VAR_057127
358 G>S No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA216528354
rs142846802
359 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1564827724 361 S>= Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA378914811
rs1438500552
362 A>T No ClinGen
TOPMed
CA378914824
rs1554899777
364 M>L No ClinGen
gnomAD
CA378914897
rs1554899782
373 R>S No ClinGen
gnomAD
rs1233999216
CA378914899
374 M>V No ClinGen
TOPMed
gnomAD
rs1345353923
CA378914916
376 D>H No ClinGen
TOPMed
CA5750626
rs558060643
377 R>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs577541215
CA5750627
379 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs577541215
CA378914941
379 T>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5750629
rs782422407
380 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA378914943
rs1416617235
380 R>W No ClinGen
TOPMed
gnomAD
CA378914946
rs1312104143
381 R>G No ClinGen
TOPMed
gnomAD
CA378914948
rs1432598689
381 R>K No ClinGen
TOPMed
gnomAD
CA378914949
rs1432598689
381 R>T No ClinGen
TOPMed
gnomAD
rs1160540854
CA378914954
382 D>H No ClinGen
TOPMed
CA378914972
rs1470603411
384 T>I No ClinGen
TOPMed
CA378914974
rs1589966022
385 L>V No ClinGen
Ensembl
rs782123141
CA5750631
388 S>L No ClinGen
ExAC
gnomAD
CA5750633
rs368579242
389 R>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs201895841
CA378915009
CA5750634
390 E>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 391 S>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5750637
rs782087412
394 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs782087412
CA378915036
394 P>Q No ClinGen
ExAC
TOPMed
gnomAD
CA378915037
rs782087412
394 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs528975381
CA5750636
394 P>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA378915038
rs868909200
395 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA5750639
rs781856912
395 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA378915040
rs868909200
395 R>S No ClinGen
gnomAD
rs1017840584
CA378915044
396 A>P No ClinGen
TOPMed
gnomAD
rs1017840584
CA216530903
396 A>S No ClinGen
TOPMed
gnomAD
rs1017840584
CA378915043
396 A>T No ClinGen
TOPMed
gnomAD
CA378915047
rs1554899819
396 A>V No ClinGen
gnomAD
CA378915055
rs1318651286
397 S>R No ClinGen
TOPMed
rs782589525
CA5750641
398 L>H No ClinGen
ExAC
gnomAD
rs1384505481
CA378915068
399 K>N No ClinGen
TOPMed
gnomAD
rs202228177
CA216530909
400 P>L No ClinGen
TOPMed
gnomAD
CA5750644
rs782682369
401 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs782438973
CA5750643
401 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA5750645
rs782274862
402 K>R No ClinGen
ExAC
gnomAD
CA216530918
rs763031271
403 V>L No ClinGen
TOPMed
gnomAD
CA378915084
rs763031271
403 V>M No ClinGen
TOPMed
gnomAD
CA5750647
rs375295573
405 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1554899832
CA378915102
406 G>R No ClinGen
gnomAD
rs551673092
CA5750650
406 G>V No ClinGen
1000Genomes
ExAC
gnomAD
CA378915111
rs1554899835
407 G>A No ClinGen
gnomAD
CA378915110
rs1554899835
407 G>D No ClinGen
gnomAD
rs1564827894
CA378915107
407 G>S No ClinGen
Ensembl
TCGA novel 408 K>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5750651
rs782173844
409 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA378915122
rs1554899837
409 R>W No ClinGen
gnomAD
CA378915144
rs1554899839
412 D>G No ClinGen
gnomAD
rs1446118930
CA378915164
415 S>G No ClinGen
TOPMed
rs565049203
CA378915166
415 S>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA5750652
rs565049203
415 S>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1446118930
CA378915163
415 S>R No ClinGen
TOPMed
CA378915168
rs1554899845
415 S>R No ClinGen
gnomAD
CA5750653
rs565049203
415 S>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1589966173
CA378915184
418 S>G No ClinGen
Ensembl
CA378915202
rs1231387109
420 D>E No ClinGen
TOPMed
CA5750655
rs782739774
420 D>N No ClinGen
ExAC
gnomAD
rs1270607536
CA378915224
423 K>N No ClinGen
TOPMed
CA5750656
rs781826005
423 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs782444066
CA5750657
425 I>V No ClinGen
ExAC
gnomAD
rs1326110834
CA378915244
426 L>R No ClinGen
TOPMed
gnomAD
rs549909505
CA5750659
428 T>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA378915276
rs1589966205
431 H>P No ClinGen
Ensembl
CA5750660
rs782537292
433 V>M No ClinGen
ExAC
gnomAD
TCGA novel 434 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs371756511
CA5750661
435 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA378915329
rs1168897611
439 V>E No ClinGen
TOPMed
rs782181700
CA5750665
439 V>M No ClinGen
ExAC
gnomAD
rs1475310205
CA378915334
440 A>P No ClinGen
TOPMed
rs1475310205
CA378915332
440 A>T No ClinGen
TOPMed
CA378915344
rs1589966253
442 T>P No ClinGen
Ensembl
rs764512888
CA378915365
444 N>K No ClinGen
gnomAD
rs782272306
CA5750668
446 Y>* No ClinGen
ExAC
gnomAD
rs1554899875
CA378915374
446 Y>H No ClinGen
gnomAD
CA378915385
rs1554899881
447 I>M No ClinGen
gnomAD
rs782375706
CA5750669
447 I>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA378915387
rs1246523958
448 F>L No ClinGen
TOPMed
gnomAD
CA5750670
rs781967676
450 D>E No ClinGen
ExAC
gnomAD

No associated diseases with Q66LE6

9 regional properties for Q66LE6

Type Name Position InterPro Accession
repeat WD40 repeat 20 - 62 IPR001680-1
repeat WD40 repeat 89 - 129 IPR001680-2
repeat WD40 repeat 171 - 210 IPR001680-3
repeat WD40 repeat 221 - 261 IPR001680-4
repeat WD40 repeat 280 - 318 IPR001680-5
repeat WD40 repeat 345 - 376 IPR001680-6
repeat WD40 repeat 412 - 449 IPR001680-7
conserved_site Protein phosphatase 2A regulatory subunit PR55, conserved site 89 - 103 IPR018067-1
conserved_site Protein phosphatase 2A regulatory subunit PR55, conserved site 180 - 194 IPR018067-2

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
protein phosphatase type 2A complex A protein complex that has protein serine/threonine phosphatase activity that is polycation-stimulated (PCS), being directly stimulated by protamine, polylysine, or histone H1; it constitutes a subclass of several enzymes activated by different histones and polylysine, and consists of catalytic, scaffolding, and regulatory subunits. The catalytic and scaffolding subunits form the core enzyme, and the holoenzyme also includes the regulatory subunit.

1 GO annotations of molecular function

Name Definition
protein phosphatase regulator activity Binds to and modulates the activity of a protein phosphatase, an enzyme which catalyzes of the removal of a phosphate group from a protein substrate molecule.

3 GO annotations of biological process

Name Definition
cell division The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
exit from mitosis The cell cycle transition where a cell leaves M phase and enters a new G1 phase. M phase is the part of the mitotic cell cycle during which mitosis and cytokinesis take place.
mitotic cell cycle Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent.

15 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5E9Q7 PPP2R2B Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Bos taurus (Bovine) PR
Q5ZIY5 PPP2R2D Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform Gallus gallus (Chicken) PR
Q9Y2T4 PPP2R2C Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform Homo sapiens (Human) PR
Q00005 PPP2R2B Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Homo sapiens (Human) PR
Q6ZWR4 Ppp2r2b Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Mus musculus (Mouse) PR
Q6P1F6 Ppp2r2a Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform Mus musculus (Mouse) PR
Q8BG02 Ppp2r2c Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform Mus musculus (Mouse) PR
P54614 PPP2R2B Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Sus scrofa (Pig) PR
P97888 Ppp2r2c Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform Rattus norvegicus (Rat) PR
P36877 Ppp2r2b Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Rattus norvegicus (Rat) PR
Q0E2P1 Os02g0224200 Serine/threonine protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Oryza sativa subsp japonica (Rice) PR
Q38821 PP2AB1 Serine/threonine protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform Arabidopsis thaliana (Mouse-ear cress) PR
Q0D2F4 ppp2r2b Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q6DIY3 ppp2r2d Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q6NY64 ppp2r2d Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MAGAGGGGCP AGGNDFQWCF SQVKGAIDED VAEADIISTV EFNYSGDLLA TGDKGGRVVI
70 80 90 100 110 120
FQREQENKSR PHSRGEYNVY STFQSHEPEF DYLKSLEIEE KINKIRWLPQ QNAAHFLLST
130 140 150 160 170 180
NDKTIKLWKI SERDKRAEGY NLKDEDGRLR DPFRITALRV PILKPMDLMV EASPRRIFAN
190 200 210 220 230 240
AHTYHINSIS VNSDHETYLS ADDLRINLWH LEITDRSFNI VDIKPANMEE LTEVITAAEF
250 260 270 280 290 300
HPHQCNVFVY SSSKGTIRLC DMRSSALCDR HSKFFEEPED PSSRSFFSEI ISSISDVKFS
310 320 330 340 350 360
HSGRYMMTRD YLSVKVWDLN MESRPVETHQ VHEYLRSKLC SLYENDCIFD KFECCWNGSD
370 380 390 400 410 420
SAIMTGSYNN FFRMFDRDTR RDVTLEASRE SSKPRASLKP RKVCTGGKRR KDEISVDSLD
430 440 450
FNKKILHTAW HPVDNVIAVA ATNNLYIFQD KIN